Silencing PPA1 inhibits human epithelial ovarian cancer metastasis by suppressing the Wnt/&#x03B2;-catenin signaling pathway

Haiying Niu; Wei Zhou; Yingxi Xu; Zhiqi Yin; Wenzhi Shen; Zhen Ye; Yanhua Liu; Yanan Chen; Shuang Yang; Rong Xiang; Lina Wang; Pengpeng Qu

doi:10.18632/oncotarget.19346

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Learn about our FREE

Post-Publication Promotion Services

50% on all publication fees until the end of 2024.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Research Papers:

Silencing PPA1 inhibits human epithelial ovarian cancer metastasis by suppressing the Wnt/β-catenin signaling pathway

Haiying Niu, Wei Zhou, Yingxi Xu, Zhiqi Yin, Wenzhi Shen, Zhen Ye, Yanhua Liu, Yanan Chen, Shuang Yang, Rong Xiang, Lina Wang _ and Pengpeng Qu

PDF | HTML | Supplementary Files | How to cite

Oncotarget. 2017; 8:76266-76278. https://doi.org/10.18632/oncotarget.19346

Metrics: PDF 1869 views | HTML 3203 views | ?

Abstract

Haiying Niu1,*, Wei Zhou2,*, Yingxi Xu3, Zhiqi Yin4, Wenzhi Shen2, Zhen Ye2, Yanhua Liu2, Yanan Chen2, Shuang Yang2, Rong Xiang2, Lina Wang3 and Pengpeng Qu5

1Department of Gynecology and Obstetrics, Tianjin First Center Hospital, Tianjin, China

2Department of Immunology, Nankai University School of Medicine, Tianjin, China

3State Key Laboratory of Experimental Hematology, Institute of Hematology and Blood Disease Hospital, Chinese Academy of Medical Sciences, Tianjin, China

4Department of Pathology, Tianjin First Center Hospital, Tianjin, China

5Department of Gynecology Oncology, Tianjin Central Hospital of Gynecology Obstetrics, Tianjin, China

*These authors have contributed equally to this work

Correspondence to:

Lina Wang, email: [email protected]

Pengpeng Qu, email: [email protected]

Keywords: PPA1, epithelial ovarian cancer, metastasis, Wnt/β-catenin

Received: January 18, 2017 Accepted: June 19, 2017 Published: July 18, 2017

ABSTRACT

Inorganic pyrophosphatase (PPA1) activity is a key determinant of cellular inorganic pyrophosphate levels, and its expression is correlated with growth of several solid tumors. To investigate this relationship, we first examined PPA1 expression in human epithelial ovarian cancer (EOC) samples, and found that PPA1 was overexpressed in tumors from EOC patients. Higher PPA1 levels correlated with advanced grades, stages, and poor survival in EOC patients. Examination of PPA1 function in EOC revealed that silencing PPA1 inhibited EOC migration, epithelial-mesenchymal transition (EMT), and metastasis in vitro and in vivo. In addition, PPA1 may promote the dephosphorylation and translocation of β-catenin. These results demonstrate that silencing PPA1 inhibits EOC metastasis by suppressing the Wnt/β-catenin signaling pathway. Strategies for downregulating PPA1 may have therapeutic potential for the prevention and treatment of EOC.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 19346

Publication Alerts

Post-Publication Promotion

Publication Discount

Research Papers:

Silencing PPA1 inhibits human epithelial ovarian cancer metastasis by suppressing the Wnt/β-catenin signaling pathway

Abstract